ArcticZymes Technologies ASA: Notice of Annual General Meeting 26
The annual general meeting ("AGM") for ArcticZymes Technologies ASA will be held on Thursday 28. May 2026 at 12.00 CET. The meeting will be held as a physical meeting, with an option for shareholders to participate digitally.
Research Paper on ArcticZymes R2D Ligase Published in the Biotechnology Journal
Tromsø, Norway, March 27, 2024 - ArcticZymes Technologies ASA (OSE: AZT) Research Paper on ArcticZymes R2D Ligase™ is published in the Biotechnology Journal
ArcticZymes Technologies ASA Q4 2023 Results & Presentation
Tromsø, Norway, February 1st, 2024 – ArcticZymes Technologies (OSE: AZT) reported sales of NOK 28.4 million and an EBITDA of NOK 2.0 million for the fourth quarter of 2023.
New Product Launch - SAN HQ GMP
Tromsø, Norway, January 30th, 2024 – ArcticZymes Technologies ASA (OSE:AZT) announces the launch of Salt Active Nuclease High Quality GMP Grade (SAN HQ GMP).
ArcticZymes Technologies launches T7 RNA Polymerase
Tromsø, Norway, December 21, 2023 – ArcticZymes Technologies ASA (OSE: AZT) announced the launch of its new product, T7 RNA Polymerase. The T7 RNA Polymerase, specifically designed for molecular research and diagnostics, caters to the specialized needs of our customers in the Molecular Tools segment.